Envista Holdings (NVST) Income from Continuing Operations (2018 - 2026)

Envista Holdings' (NVST) quarterly Income from Continuing Operations came in at 38700000.0 in Q2 2026, up 115.0% year-on-year from 18000000.0 in Q2 2025, and up 17.63% quarter-over-quarter from 32900000.0 in Q4 2025.

Envista Holdings (NVST) Income from Continuing Operations (2018 - 2026) Analysis & Trends

Envista Holdings' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 38700000.0 for Q2 2026.

  • On a quarterly basis, Income from Continuing Operations rose 115.0% year-over-year to 38700000.0 in Q2 2026; TTM through Apr 2026 was 67700000.0, a 106.02% increase from a year earlier, with the FY2025 full-year figure at 47000000.0, up 104.2% from the prior year.
  • Income from Continuing Operations rose to 38700000.0 in Q2 2026 per NVST's latest filing, from 32900000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 73500000.0 in Q4 2022 and bottomed at 1151600000.0 in Q2 2024.
  • The 5-year median for Income from Continuing Operations is 26400000.0 (2025), against an average of 52652941.18.
  • Across the five-year window, Income from Continuing Operations slumped 2318.88% in 2024 and surged 2641.67% in 2025, its largest moves.
  • Year by year, Income from Continuing Operations stood at 73500000.0 in 2022, then sank by 395.78% to 217400000.0 in 2023, then jumped by 100.55% to 1200000.0 in 2024, then jumped by 2641.67% to 32900000.0 in 2025, then grew by 17.63% to 38700000.0 in 2026.
  • Per Business Quant, the three latest NVST Income from Continuing Operations figures stand at 38700000.0 (Q2 2026), 32900000.0 (Q4 2025), and 30300000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 240.00 Mn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 823.20 Mn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -37.00 Mn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 239.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 398.73 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 147.90 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -77.90 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 13.00 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 112.77 Mn
10 Envista Holdings 4.29 Bn 3.20 Bn 390.10 Mn 38.70 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 38.70 Mn
Dec 31, 2025 32.90 Mn
Sep 26, 2025 -30.30 Mn
Jun 27, 2025 26.40 Mn
Mar 28, 2025 18.00 Mn
Dec 31, 2024 1.20 Mn
Sep 27, 2024 8.20 Mn
Jun 28, 2024 -1.15 Bn
Mar 29, 2024 23.60 Mn
Dec 31, 2023 -217.40 Mn
Sep 29, 2023 21.50 Mn
Jun 30, 2023 51.90 Mn
Mar 31, 2023 43.80 Mn
Dec 31, 2022 73.50 Mn
Sep 30, 2022 49.60 Mn
Jul 1, 2022 44.50 Mn
Apr 1, 2022 70.40 Mn
Dec 31, 2021 42.50 Mn
Oct 1, 2021 80.20 Mn
Jul 2, 2021 79.00 Mn